| abstract |
The present invention provides a compound of the formula (I ′) having a CRF receptor antagonistic activity or a salt thereof, or a prodrug thereof, and a use thereof. [Solution] [Wherein, X represents nitrogen or CRx (Rx is hydrogen or the like), R 1 represents an optionally substituted hydrocarbon group or the like, and R 2 represents an optionally substituted hydrocarbon group or the like. Ring A represents a 5- to 8-membered heterocyclic ring, and Y 1 , Y 2 and Y 3 each represents optionally substituted carbon or nitrogen. ] [Selection figure] None |